Major Release of 吃瓜爆料 Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense

Fixed price implementation to get up and running quickly

Industry advances to connected trials as seven of the top 20 biopharmas adopt 吃瓜爆料 Site Connect

PLEASANTON, CA — Sep. 5, 2024 — 吃瓜爆料 Systems (NYSE: VEEV) today announced, in a major step forward for clinical trial execution, the newest release of 吃瓜爆料 Site Connect, adding powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site collaboration. With 吃瓜爆料 Site Connect, sponsors reduce the time and effort of site start-up, study conduct, and closeout for higher-quality trials at a significantly lower cost.

“By standardizing how information is shared across all sites in one application with 吃瓜爆料 Site Connect, we aim to save time and effort that can be focused on treating patients,” said a clinical operations excellence leader at a top 20 biopharma. “Our goal is to eliminate manual handoffs and inefficiencies for faster site start-up, more efficient monitoring, and simplified study closeout.”

To deliver better trial execution in less time, the expansion of 吃瓜爆料 Site Connect includes major application and implementation advances.

New capabilities expand Site Connect beyond document exchange and safety distribution: 吃瓜爆料 Site Connect adds Study Communications, Contacts, Payment Information, and quick links to sponsor systems to already powerful Document Exchange and Safety Distribution capabilities.
Optimized site user interface that’s the same for all trials: Organizing everything sites need in an intuitive site homepage with simple sidebar navigation means sites can easily stay informed and close out tasks in just a few clicks. Having the same user experience for all trials gives sites a standard way to work across sponsors.

吃瓜爆料 Site Connect gives easy access to everything sites need in just a few clicks.
Open for use by any site, anywhere: 吃瓜爆料 Site Connect is accessible for all sites everywhere. Sites that use as their eISF get the added benefit of connecting their study for seamless bidirectional document exchange.
Simple fixed price implementation to get up and running in two to four months: With a standard fixed fee engagement of two to four months, depending upon company size, sponsors can make a big impact quickly toward their goal of faster, higher quality trial execution.

“I would be ecstatic if all our sponsors use 吃瓜爆料 Site Connect. It gives sites a much more efficient way to collaborate with sponsors, maintain regulatory compliance, and get critical therapies to patients faster,” said Alisha Garibaldi, CEO, Skylight Health Research. “The less time we spend doing administrative work in systems, the more time we have to execute trials and help patients.”

"By implementing 吃瓜爆料 Site Connect for our safety letter distribution process, we anticipate achieving a significant reduction in manual processing while enhancing oversight and compliance," said Marta Jureczko-Hinzmann, head of global clinical solution services at AstraZeneca. "Sharing safety letters across all sites globally within a single application will allow us to harmonize the entire process across the company and optimize how we allocate valuable resources.”

吃瓜爆料 Site Connect is part of 吃瓜爆料 Clinical Platform, the complete and connected solution supporting patients, sites, and sponsors. 吃瓜爆料 Site Connect plays a critical role as the industry moves to simplify and standardize site collaboration, and seven of the top 20 biopharmas have already adopted 吃瓜爆料 Site Connect to streamline trials.

See the 吃瓜爆料 Site Connect demo and learn more at 吃瓜爆料 R&D and Quality Summit September 9-10 in Boston, where top biopharmas will share how they use 吃瓜爆料 Site Connect to simplify trial execution for greater quality and speed.

Additional Information
For more on 吃瓜爆料 Site Connect, visit: veeva.com/吃瓜爆料SiteConnect
Connect with 吃瓜爆料 on LinkedIn:

About 吃瓜爆料 Systems
吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2024 and in our subsequent SEC filings, which you can access at .

###

Contact:
Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com